AGTR1 and diabetes mellitus: Gao et al. discovered that resveratrol can reduce cardiac dysfunction and fibrosis induced by diabetes, an effect associated with a reduction in the inflammatory response and the down-regulation of the AT1R-ERK/p38 MAPK signaling pathway [40].